Table I.
Clinical feature | Cases (n) | miR-411 expression
|
P-value | |
---|---|---|---|---|
Low | High | |||
Age | 0.257 | |||
<50 years | 59 | 37 | 22 | |
≥50 years | 55 | 28 | 27 | |
Tumor diameter | 0.230 | |||
<2 cm | 76 | 40 | 36 | |
≥2 cm | 38 | 25 | 13 | |
Lymph node metastasis | 0.034 | |||
Negative | 46 | 32 | 14 | |
Positive | 68 | 33 | 35 | |
Stage | 0.349 | |||
I–II | 50 | 26 | 24 | |
III | 64 | 39 | 25 | |
Histological grade | 0.003 | |||
I–II | 72 | 49 | 23 | |
III | 42 | 16 | 26 | |
HER2 expression | 0.456 | |||
Negative | 56 | 34 | 22 | |
Positive | 58 | 31 | 27 | |
Ki-67 expression | 0.848 | |||
Negative | 46 | 27 | 19 | |
Positive | 68 | 38 | 30 | |
P53 expression | 0.835 | |||
Negative | 33 | 18 | 15 | |
Positive | 81 | 47 | 34 |
miR, microRNA; HER2, human epidermal growth factor receptor 2.